Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NT 201 (incobotulinumtoxinA) for post-stroke upper limb spasticity
jRCT2080222976Phase 3Completed
- Sponsor
- Merz
- Start
- Oct 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of botulinum toxin type A in poststroke spasticity (PSS) and Muscle spasm (5 arms), sponsored by Merz. Started Oct 2015; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
poststroke spasticity (PSS)Muscle spasm
Beyond the preview
Go deeper on jRCT2080222976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222976.